UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000000905
Receipt No. R000001086
Scientific Title Immunotherapy Using HLA-A24-restricted Survivin-derived Peptide Mixed with IFA, IFA and IFN-alpha, IFA and IL-2, or IFA and GM-CSF for Patients with Digestive Cancer and Endocrine Organic Cancer (Phase I clinical study)
Date of disclosure of the study information 2007/11/23
Last modified on 2007/11/24 10:08:33

No. Disposal Last modified on Item of update
1 Insert 2007/11/23 22:27:58
2 Update 2007/11/24 10:08:33 Recruitment status


Contact us.